Grant: Discovery Grants Program - Individual
Université de Montréal
$64,000.00
The dynamics of mucosal cytomegalovirus replication and barriers to dissemination during acquisition of infection
EF 2022-23
Résumé
Cytomegalovirus (CMV) infects more than 90% of humans, and is primarily acquired at mucosal surfaces. Upon exposure, CMV initially replicates in mucosal epithelium and then spreads to establish life-long infection in distant anatomic sites. However, we have found that CMV acquisition is highly inefficient in humans, and infection is frequently transient without spread beyond the mucosa. We have determined that these natural CMV transmission dynamics are best explained by weak cell-to-cell spread from only 1 or very few infected mucosal cells at the start of infection. Thus, although life-long CMV infection eventually becomes established in most people, this typically occurs only after large numbers of exposures, most of which many are rapidly extinguished.This project aims to better define the basis of this severe transmission bottleneck, to understand why CMV infection does not occur. We will elucidate the earliest events of CMV acquisition, using in vitro, murine, and mathematical models to define the viral and host conditions that determine whether mucosal CMV replication persists and spreads, or terminates following exposure to a range of viral inoculum sizes. We hypothesize that CMV dynamics in mucosal epithelium are influenced by stochastic as well as host immune factors, and that infection terminates when viral replication does not reach a threshold required for dissemination. We also predict that innate immune barriers can be overcome by larger viral inocula. We will address these questions following specific aims: Aim 1: Define the dynamics of CMV mucosal replication and spread in cultured cells and mice. We will use wild-type and recombinant CMV strains to measure viral expansion in cultured epithelial cells and in the mucosa of mice by live bioimaging, PCR, and histopathology. We will also determine the frequency of self-limited mucosal infections vs. disseminated infections over a range of inoculum sizes.Aim 2: Identify the role of host innate immunity in determining successful CMV infection. We will identify the immune responses that constrain CMV spread in mucosal cells, by inducing or blocking antiviral factors as well as transcriptomics using in vitro and murine systems, including knock-out mice.Aim 3: Construct mathematical models to elucidate determinants of successful CMV infection. Detailed in vitro and murine data will be used to supplement our extensive human data, and allow refinement and expansion of our mathematical models of CMV acquisition. Model predictions will represent hypotheses to be tested in further rounds of experiments.This work will be conducted by pre- and postdoctoral trainees, in a highly collaborative interdisciplinary learning environment at UBC. By integrating state-of-the-art virology, immunology, and mathematical modeling data, we will gain fundamental insights into the determinants of whether a natural CMV infection succeeds or fails.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2018-05666
Name nom
Gantt, Soren
Department département
Pediatrics - Pediatrics
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2018
Award amount
64000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Installment
inst:5;6
Partie
2
Nb partie
6
Application title
The dynamics of mucosal cytomegalovirus replication and barriers to dissemination during acquisition of infection
Application summary
Cytomegalovirus (CMV) infects more than 90% of humans, and is primarily acquired at mucosal surfaces. Upon exposure, CMV initially replicates in mucosal epithelium and then spreads to establish life-long infection in distant anatomic sites. However, we have found that CMV acquisition is highly inefficient in humans, and infection is frequently transient without spread beyond the mucosa. We have determined that these natural CMV transmission dynamics are best explained by weak cell-to-cell spread from only 1 or very few infected mucosal cells at the start of infection. Thus, although life-long CMV infection eventually becomes established in most people, this typically occurs only after large numbers of exposures, most of which many are rapidly extinguished.This project aims to better define the basis of this severe transmission bottleneck, to understand why CMV infection does not occur. We will elucidate the earliest events of CMV acquisition, using in vitro, murine, and mathematical models to define the viral and host conditions that determine whether mucosal CMV replication persists and spreads, or terminates following exposure to a range of viral inoculum sizes. We hypothesize that CMV dynamics in mucosal epithelium are influenced by stochastic as well as host immune factors, and that infection terminates when viral replication does not reach a threshold required for dissemination. We also predict that innate immune barriers can be overcome by larger viral inocula. We will address these questions following specific aims: Aim 1: Define the dynamics of CMV mucosal replication and spread in cultured cells and mice. We will use wild-type and recombinant CMV strains to measure viral expansion in cultured epithelial cells and in the mucosa of mice by live bioimaging, PCR, and histopathology. We will also determine the frequency of self-limited mucosal infections vs. disseminated infections over a range of inoculum sizes.Aim 2: Identify the role of host innate immunity in determining successful CMV infection. We will identify the immune responses that constrain CMV spread in mucosal cells, by inducing or blocking antiviral factors as well as transcriptomics using in vitro and murine systems, including knock-out mice.Aim 3: Construct mathematical models to elucidate determinants of successful CMV infection. Detailed in vitro and murine data will be used to supplement our extensive human data, and allow refinement and expansion of our mathematical models of CMV acquisition. Model predictions will represent hypotheses to be tested in further rounds of experiments.This work will be conducted by pre- and postdoctoral trainees, in a highly collaborative interdisciplinary learning environment at UBC. By integrating state-of-the-art virology, immunology, and mathematical modeling data, we will gain fundamental insights into the determinants of whether a natural CMV infection succeeds or fails.